AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

New test discovers breast cancer at early, most treatable stage.

Women's Health Weekly

| October 07, 2004 | COPYRIGHT 2004 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

2004 OCT 7 - (NewsRx.com & NewsRx.net) -- Doctors may soon have a new tool - a noninvasive, painless nipple fluid test - in their fight to make breast cancer a more treatable, nonfatal disease.

Within the next couple years, women will be able to go for a routine check-up and receive the test - currently in development at IMI International Medical Innovations - that can detect breast cancer in its early, most treatable stage. IMI's breast cancer test identifies a cancer-associated sugar in a sample of nipple aspirate fluid derived from the breast ducts and painlessly expressed through the nipple using a pump.

"Most breast cancers originate in the breast ducts, so nipple aspirate fluid is a logical sample to target," said Dr. Anees Chagpar, an assistant professor in the division of surgical oncology, University of Louisville (Kentucky). "The early results we have seen with this test are promising, and we are planning additional studies to confirm and expand our ...

Related articles from newspapers, magazines, journals, and more
Two drinks a day increases risk of breast cancer, study shows.
Magazine article from: Women's Health Weekly March 4, 2004 700+ words
...MD, founder of The Breast Cancer Care & Research...or hopeful time for breast cancer research and treatment...for their particular breast cancer." This article was prepared by Women's Health Weekly editors from staff...
Irsogladine side-steps angiogenic function to stop breast cancer metastasis.
Magazine article from: Women's Health Weekly March 25, 2004 700+ words
...agent, irsogladine. Breast Cancer Res Treat, 2004...publisher of the journal Breast Cancer Research and Treatment...Gastroenterology, Oncology, and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
Change on enzyme gene may associate with invasive disease.(breast cancer...
Magazine article from: Women's Health Weekly January 9, 2003 700+ words
...than women without breast cancer carried a polymorphism...MMP-3 * Women whose breast cancer had spread were more...metastasis in women with breast cancer This article was prepared by Women's Health Weekly editors from staff...
Protein tyrosine phosphatase gamma is a tumor suppressor gene in breast cancer.
Magazine article from: Women's Health Weekly April 1, 2004 700+ words
...independent growth of breast cancer cells in soft agar...PTP gamma) in human breast cancer cell line MCF-7...Enzymology, Oncology and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
HCCR-2 related to breast cancer development and p53 tumor suppressor regulation.
Magazine article from: Women's Health Weekly May 6, 2004 700+ words
...Transgenic mouse model for breast cancer: induction of breast cancer in novel oncogene HCCR...Biotechnology, Oncogenesis and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff and other...
Older breast cancer patients in Canada benefit from early detection.
Magazine article from: Women's Health Weekly June 24, 2004 700+ words
...year survival of 2192 breast cancer women diagnosed between...Survival of women with breast cancer in Ottawa, Canada...amp; Mortality, and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
Gene patterns in the ERBB2/TOP2A region of breast cancer influence outcomes.
Magazine article from: Women's Health Weekly June 17, 2004 700+ words
...ERBB2/TOP2A region of breast cancer influence outcomes...ERBB2/TOP2A region in breast cancer. Gene Chromosome Cancer...Oncogenesis, Oncology and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
Cystatin M is a novel candidate tumor suppressor gene for breast cancer.
Magazine article from: Women's Health Weekly December 30, 2004 700+ words
...suppressor gene for breast cancer," Zhang concluded...suppressor gene for breast cancer. Cancer Res, 2004...Suppressor Gene and Breast Cancer. This article was prepared by Women's Health Weekly editors from staff...
For more facts and information, see all results

Source: HighBeam Research, New test discovers breast cancer at early, most treatable stage.

©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA